AVS is a medical device company specializing in pulsatile intravascular lithotripsy, a novel technology used to disrupt intravascular calcium.
Location: United States, Michigan, Ann Arbor
Total raised: $28.8M
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.04.2023 | Series B | $8.8M | - |
| 05.01.2023 | Series B | $20M | - |
Mentions in press and media 8
| Date | Title | Description |
| 27.07.2023 | Medical Devices Are Evolving Toward Specialized Solutions | Medical devices have existed in some form for centuries, resulting in thousands of innovative implementations over the years. Throughout history, medical devices have addressed a wide array of disease states – often, one device has purpose ... |
| 04.04.2023 | Calcified arterial disease device company AVS adds $8.8M to its Series B funding | The funding is in addition to its $20 million round raised in January AVS (Amplitude Vascular Systems) is a company creating a new treatment option for pulsatile intravascular lithotripsy (PIVL), an emerging, minimally invasive treatment fo... |
| 04.04.2023 | AVS Closes Additional $8.8M in Series B Funding | AVS, a Boston, MA-based medical device company, raised additional $8.8M in Series B funding. The round, which brought the total amount of its Series B to $28.8M, was led by BioStar Capital with CUE Growth Partners. The company intends to us... |
| 04.04.2023 | Med Device AVS Raises Additional $8.8M for $28.8M Series B | What You Should Know: – AVS, an early-stage medical device company focused on safely and effectively treating severely calcified arterial disease with its PIVL™ therapy, announced today that it closed an additional $8.8 million in new finan... |
| 05.01.2023 | AVS Rakes in $20M to Advance Plaque-shattering Arterial Disease Treatment | Boston-based medical device company AVS (Amplitude Vascular Systems) raised $20 million in Series B funding on Thursday to bring its arterial disease treatment closer to FDA clearance. The financing round, which brings the startup’s total f... |
| 05.01.2023 | AVS Raises $20M in Series B Funding Round | AVS, a Boston, MA-based early-stage medical device company, raised $20M in Series B funding. The round was led by BioStar Capital. The company intends to use the funds to accelerate clinical trial timelines for its device for peripheral app... |
| 05.01.2023 | AVS raises $20M to develop its medical device focused on calcified arterial disease | The company will use the funding to complete clinical trials to support FDA clearance Vascular calcification is a common condition that has been shown to increase the risk of major cardiovascular events, such as heart attacks, strokes, or b... |
| - | Amplitude Vascular Systems | “Cross, Pulse, Shatter and Expand with PIVL™ | AVS Pulse” |